Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. - Wikidata - awgldk - TriplyDB

Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.

Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.

http://www.wikidata.org/entity/Q35023404

about

Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)Dormancy of growth-stunted malignant melanoma: sustainable and smoldering patterns Emerging clinical applications of selected biomarkers in melanoma Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).Myosin-1E interacts with FAK proline-rich region 1 to induce fibronectin-type matrix.Cutaneous melanoma in women.Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases.Melanoma epidemiology, biology and prognosis.Diagnostic and prognostic biomarkers in melanoma.Age as a prognostic factor in patients with localized melanoma and regional metastases.Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence.Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.The clinicopathological and gene expression patterns associated with ulceration of primary melanoma Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness.High nevus counts confer a favorable prognosis in melanoma patients.Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique Molecular profiling reveals low- and high-grade forms of primary melanoma.Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial.Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis.Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study.Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanoma Construction and analysis of multiparameter prognostic models for melanoma outcome Prognostic impact of PHIP copy number in melanoma: linkage to ulceration.Improving Melanoma Path Reports: the Importance of Histopathological Parameters in Diagnosis of Cutaneous Melanoma.Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate.Advances in sentinel lymph node mapping for patients with melanoma.Using antibodies to target cancer therapeutics.Isolated limb perfusion for in-transit melanoma metastases: melphalan or TNF-melphalan perfusion?Tissue prognostic biomarkers in primary cutaneous melanoma.A review of sentinel lymph node biopsy for thin melanoma.Sentinel lymph node biopsy for cutaneous head and neck malignancies.Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center.iDermatoPath - a novel software tool for mitosis detection in H&E-stained tissue sections of malignant melanoma.Antineoplastic effects of Rhodiola crenulata treatment on B16-F10 melanoma.Biomarkers of cancer metastasis through the lymphovascular system: future perspectives.National Evaluation of Hospital Performance on the New Commission on Cancer Melanoma Quality Measures.De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.A Novel Numerical Scoring System for Melanoma Tumor-infiltrating Lymphocytes Has Better Prognostic Value Than Standard Scoring.

P2860

Q26770492-49BF8676-3FE4-4A6C-B16C-8D270A225D1C Q28083204-69D5E125-4842-4C4B-811D-9807B13AA64E Q28087169-4AD6A7A7-95A1-4162-A098-0A310E12B89D Q30669529-AA1D4961-AFB6-4AEF-AA45-5807BD5F52BA Q33569347-E76D8A1A-08A2-4154-BCE6-935F5AA7CDBE Q33641691-47B64215-C98C-47CB-A07C-0BBA712C67F4 Q33687123-8D94C48E-B73F-4EEA-9B11-A76DD5BFC93C Q33698718-AF048C3E-5FB3-45B6-91FC-7A9F2D66B655 Q33862470-FA6B1A95-0441-4E9F-8F85-B67DB63D0138 Q34000273-FE897E47-67E0-4207-94CC-B06EBD6DCE0B Q34235463-2425FC6E-80DA-4AFE-92FC-9EC805C91C60 Q34515007-23290A37-9E6F-453B-8978-577D36D6C181 Q34772146-3D7FE7A7-3869-46D2-9A84-FA4EBB6DB207 Q35603114-710DFC30-40DF-42A9-A8F4-2C508B8C9D07 Q35855182-ED88B597-01A9-4420-A78D-F0B50B1AF34E Q35856609-4888D4A1-4DBB-46FE-AAC4-0A4F0BA52A21 Q36155641-1230B3E5-CF09-4B11-874E-2B6607C8A52E Q36305788-D5EA6881-1221-4120-85EC-F6AF4EE67741 Q36534799-B2258FC8-4B43-4AAE-AF60-9E74E54AB61F Q36844251-59DDF999-EEB0-4F3D-ADAD-F372F52E315F Q37273985-7B2753CA-3ED2-443C-B6FC-AAB5A30CAE8A Q37400708-1B3BC7CC-2D57-4185-BA9C-ADCDF578AEA6 Q37514256-61CB4C85-9A89-4078-A894-932BF64625D0 Q37550749-167ACDAD-B169-463E-8103-B86E38E0F877 Q37623173-7D27B7EE-5794-44D0-8B30-9E0EC9FAE992 Q37669014-DBB49A51-8D1D-423B-BD78-F3B8E8128832 Q37920834-47F9C3D6-7D61-4BBE-83AA-D66D17F6C948 Q37984125-EDDE49B7-3DB6-42DB-9FA2-44705B5707F6 Q38014920-DB5760FF-DA75-461C-848B-CEAFED1AC4B0 Q38176854-3DE7D3FE-B9EC-4F18-90EF-BD0AE3FF0069 Q38184377-7051EB88-73AD-4917-8788-BF63826D1FA5 Q38264727-0BB4A89D-A922-438F-BED2-04C6A00B7052 Q38286125-6DE6EE39-E7FA-4363-9ADD-7D4BF82CBF35 Q38668386-EF39FC3B-0E35-48F4-A145-F3D7D99B0029 Q38767995-C327C6F4-4182-4CB5-AC0F-1FA4E285F010 Q38854848-BBE90652-E6CF-4AEC-B527-D752AFFC7D23 Q39569308-525A1373-5D54-45FC-8D22-BC850F8E4FED Q39698969-3E22F5E2-066C-4674-B5FC-7B2AEB5C0059 Q39729548-FE39302E-24CA-407E-8B7A-E8C4E54ABB8C Q40262319-4B426C7C-28F2-41CB-B528-46854106AF0B

P2860

Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.

http://www.wikidata.org/entity/Q35023404

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Prognostic significance of mit ...... cer melanoma staging database.

@ast

Prognostic significance of mit ...... cer melanoma staging database.

@en

type

label

Prognostic significance of mit ...... cer melanoma staging database.

@ast

Prognostic significance of mit ...... cer melanoma staging database.

@en

prefLabel

Prognostic significance of mit ...... cer melanoma staging database.

@ast

Prognostic significance of mit ...... cer melanoma staging database.

@en

P1433

Q35023404-1352FDAD-1AB4-4E5B-BD16-8CC9681D768A

P1476

Q35023404-611A0255-393E-4D93-81F3-9F565C37858E

P2093

Q35023404-01826CF6-BC1D-4884-9670-24F4C3A67BC4

Q35023404-1E0732A2-A408-41EC-B8E8-EE848CC75955

Q35023404-2A6AC174-49CD-41EE-80C3-632451E48678

Q35023404-2AF1FFD4-B928-4CAD-B1D1-C3A38400B523

Q35023404-2F47FDDE-EF9E-42DB-B7DC-82C68B19AC12

Q35023404-558BBFF2-B5C7-4BBD-BE39-F6D617839D60

Q35023404-988EE868-F152-4758-A027-27A361E61917

Q35023404-999B3126-52E1-4F90-A073-63043F42F052

Q35023404-A56DC7B6-9DC2-4695-888B-3BECD3C49C7E

Q35023404-C3601758-5D2C-40C3-8139-3CA97D5DA252

P2860

Q35023404-016CDEF2-2ADB-4975-A884-44A591714949

Q35023404-051CB700-52CC-4F21-ACB9-3175C492BB08

Q35023404-27DBF223-FDAE-4B8C-87B9-F3E19B28777E

Q35023404-4CDF7B6B-7F80-44C0-930A-56A90444575D

Q35023404-7014AFCC-BC5A-47CC-A414-0F685336B240

Q35023404-AC071C3D-9EBF-4268-99E2-DEDB0BEF6D4B

Q35023404-BA75158C-CC8A-4F0B-A721-EE4BADF50275

Q35023404-BB422789-9554-4186-BEA8-4479A0CC8F44

Q35023404-C2DD20F6-86B4-4D7F-B6F9-F2209CA50E6F

Q35023404-CF39572E-D325-44F7-8493-BD09DCFF5DF3

P304

Q35023404-95EFEDF8-CCEA-4BC2-8EB2-2FB99320EAFA

P31

Q35023404-392F3BB3-D321-4710-92E2-1CEB8C128DE8

P356

Q35023404-FED15755-6609-4301-973B-D2DB31ED6362

P407

Q35023404-535C0CBE-E1F6-4329-98B8-7680F13A4EB7

P433

Q35023404-13B016D9-65CC-4DFC-AFA3-83831E26F3AF

P478

Q35023404-7EE31C0B-4D76-4E8B-878B-187B56AB0594

P50

Q35023404-CEE8FFB2-BF71-4A5B-94B3-FCE8B6B7CE76

Q35023404-D2C9EBE0-018C-4C3D-8540-C254B98647DF

Q35023404-FA4F5B43-8521-4AB2-99B5-A87F1B9EFD05

P577

Q35023404-86715485-EB29-4434-BEB7-06E4BF6678E8

P5875

Q35023404-4CED04B4-3265-4C7A-89BB-8113E3BDA370

P698

Q35023404-CAD4FF78-2055-418D-9A11-D9CF1C5FDE7E

P921

Q35023404-464547A4-83A5-4350-AA8A-C3FB234D52E4

Q35023404-97D2B036-8D85-4FC3-9752-D9533D4AD5E4

P932

Q35023404-8B2F6DCF-4DCA-4D37-A716-E6867E601B69

P356

JCO.2010.31.5812

P1433

Journal of Clinical Oncology

P1476

Prognostic significance of mit ...... cer melanoma staging database.

@en

P2093

Alexander M Eggermont

http://www.w3.org/2001/XMLSchema#string

Alistair J Cochran

http://www.w3.org/2001/XMLSchema#string

Charles M Balch

http://www.w3.org/2001/XMLSchema#string

Daniel G Coit

http://www.w3.org/2001/XMLSchema#string

David R Byrd

http://www.w3.org/2001/XMLSchema#string

Donald L Morton

http://www.w3.org/2001/XMLSchema#string

Jeffrey E Gershenwald

http://www.w3.org/2001/XMLSchema#string

John F Thompson

http://www.w3.org/2001/XMLSchema#string

Kelly M McMasters

http://www.w3.org/2001/XMLSchema#string

Marcella M Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Final version of 2009 AJCC melanoma staging and classification

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.

Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.

Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.

The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.

Completeness of histopathology reporting of melanoma in a high-incidence geographical region.

Pathology review of thin melanoma and melanoma in situ in a multidisciplinary melanoma clinic: impact on treatment decisions.

Mitotic rate in melanoma: a reexamination.

P304

2199-2205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.31.5812

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Eggermont

P577

2011-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51075961

http://www.w3.org/2001/XMLSchema#string

P698

21519009

http://www.w3.org/2001/XMLSchema#string

P921

P932

3107741

http://www.w3.org/2001/XMLSchema#string